Mary Elizabeth Henderson

CIK: 0001989533

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (21.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)7 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

JAZZ

Jazz Pharmaceuticals plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

JAZZ
Jazz Pharmaceuticals plc
Sep 8, 2026
Tax Payment(F)
Direct
15 shares at avg. $241.20$4K
JAZZ
Jazz Pharmaceuticals plc
Sep 8, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $243.03$343K
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $241.39$501K
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
16 shares at avg. $244.64$4K
JAZZ
Jazz Pharmaceuticals plc
Mar 5, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $186.75$260K
JAZZ
Jazz Pharmaceuticals plc
Feb 26, 2026
Sale(S)
Direct
5.3K shares at avg. $194.49$1.0M
JAZZ
Jazz Pharmaceuticals plc
Feb 26, 2026
Award(A)
Direct
4.4K shares-
JAZZ
Jazz Pharmaceuticals plc
Jan 16, 2026
Award(A)
Direct
10.1K shares-
JAZZ
Jazz Pharmaceuticals plc
Dec 9, 2025
Sale(S)
Direct
2.2K shares at avg. $169.51$379K
JAZZ
Jazz Pharmaceuticals plc
Nov 19, 2025
Disposition(D)
Direct
1.3K shares at avg. $180.40$240K
JAZZ
Jazz Pharmaceuticals plc
Mar 7, 2025
Disposition(D)
Direct
698 shares at avg. $138.23$96K
JAZZ
Jazz Pharmaceuticals plc
Feb 27, 2025
Award(A)
Direct
3.9K shares-
JAZZ
Jazz Pharmaceuticals plc
Feb 27, 2025
Award(A)
Direct
5.4K shares-
JAZZ
Jazz Pharmaceuticals plc
Sep 6, 2024
Sale(S)
Direct
1.4K shares at avg. $108.30$153K

		Type	Shares	Price		Ownership
Sep 8, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	15	$241.20	$3,618	Direct
Sep 8, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,412	$243.03	$343,158	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	2,076	$241.39	$501,126	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	16	$244.64	$3,914	Direct
Mar 5, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,394	$186.75	$260,325	Direct
Feb 26, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	5,343	$194.49	$1,039,134	Direct
Feb 26, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	4,447	-	$0	Direct
Jan 16, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	10,116	-	$0	Direct
Dec 9, 2025	JAZZ Jazz Pharmaceuticals plc	Sale(S)	2,238	$169.51	$379,366	Direct
Nov 19, 2025	JAZZ Jazz Pharmaceuticals plc	Disposition(D)	1,331	$180.40	$240,112	Direct
Mar 7, 2025	JAZZ Jazz Pharmaceuticals plc	Disposition(D)	698	$138.23	$96,485	Direct
Feb 27, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	3,852	-	-	Direct
Feb 27, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	5,392	-	-	Direct
Sep 6, 2024	JAZZ Jazz Pharmaceuticals plc	Sale(S)	1,410	$108.30	$152,703	Direct

1-14 of 14 transactions

About Henderson Mary Elizabeth

Henderson Mary Elizabeth (SEC CIK 0001989533) files insider reports with the SEC as SVP, Technical Operations of Jazz Pharmaceuticals plc (JAZZ).

Signal8 holds 10 ownership filings by Henderson Mary Elizabeth, all Form 4s, filed between Sep 11, 2024 and Sep 10, 2026. Those filings report 14 transactions, from Sep 6, 2024 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Henderson Mary Elizabeth's filings is in DUBLIN 4.

Recent filings by Henderson Mary Elizabeth

Sep 8, 2026: Tax withholdings of JAZZ shares (2 lines, Form 4, code F).
Aug 31, 2026: Tax withholdings of JAZZ shares (2 lines, Form 4, code F).
Mar 5, 2026: Tax withholding of JAZZ shares (Form 4, code F).
Feb 26, 2026: Open-market sale of JAZZ shares (Form 4, code S).
Feb 26, 2026: Grant or award of JAZZ shares (Form 4, code A).

Other insiders filing for Jazz Pharmaceuticals plc (JAZZ)

GALA RENEE D, President & CEO
COZADD BRUCE C, Director
Patil Neena M, EVP & Chief Legal Officer
Smith Mark Douglas, Director
RIEDEL NORBERT G, Director
LOVE TED W, Director

How to read Form 4 transaction codes